Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2014 16:01 ET | Source: Novavax, Inc.

Novavax Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering

GAITHERSBURG, Md., June 11, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
June 05, 2014 20:55 ET | Source: Novavax, Inc.

Novavax Prices Public Offering of Common Stock

GAITHERSBURG, Md., June 5, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
June 04, 2014 16:01 ET | Source: Novavax, Inc.

Novavax Announces Proposed Public Offering of Common Stock

GAITHERSBURG, Md., June 4, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
June 02, 2014 17:40 ET | Source: Novavax, Inc.

Novavax to Present at the Jefferies 2014 Global Healthcare Conference

GAITHERSBURG, Md., June 2, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer, will...
May 12, 2014 09:00 ET | Source: Novavax, Inc.

One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response

Sustained levels of RSV F antibody and palivizumab-competing antibody responses demonstrated over a 4 to 6 month period Results support accelerating development plans for "seasonal" elderly...
May 07, 2014 16:05 ET | Source: Novavax, Inc.

Novavax Reports First-Quarter 2014 Financial Results

GAITHERSBURG, Md., May 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
May 06, 2014 16:30 ET | Source: Novavax, Inc.

Novavax Appoints Sven Andreasson as Senior Vice President, Corporate Development

GAITHERSBURG, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
May 01, 2014 11:38 ET | Source: Novavax, Inc.

Novavax to Report First Quarter Financial Results on May 7, 2014

GAITHERSBURG, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014 after the close of...
April 30, 2014 08:00 ET | Source: Novavax, Inc.

New Experimental Vaccine Produces Immune Response Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

BALTIMORE and GAITHERSBURG, Md., April 30, 2014 (GLOBE NEWSWIRE) -- The University of Maryland School of Medicine (UM SOM) and Novavax, Inc. (Nasdaq:NVAX) today announced that an investigational...
April 28, 2014 16:13 ET | Source: Novavax, Inc.

Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate in Women of Childbearing Age

Vaccine candidate was well-tolerated with no vaccine-related serious adverse events Highest immune responses observed with a single dose of vaccine combined with aluminum phosphate...